Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria K Baxter

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2017
ADP-ribosylhydrolase activity of Chikungunya virus macrodomain is critical for virus replication and virulenceRobert Lyle McPherson, Rachy Abraham, Easwaran Sreekumar, et al.
Plos One|December 11, 2013
Serum albumin and body weight as biomarkers for the antemortem identification of bone and gastrointestinal disease in the common marmosetVictoria K Baxter, Gillian C Shaw, Nathaniel P Sotuyo, et al.
Plos Pathogens|July 10, 2026
Characterization of an immunocompetent, young adult mouse model for studying chikungunya virus neuroinvasion and central nervous system infectionAlyssa M Lantz, Freedom M Green, Amanda J Cowan, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Pharmacokinetic considerations for optimizing inhaled spray-dried pyrazinoic acid formulationsShekhar B Yeshwante, Patrick Hanafin, Brittany K Miller, et al.
Molecular Pharmaceutics|August 17, 2023
Pharmacokinetic Considerations for Optimizing Inhaled Spray-Dried Pyrazinoic Acid FormulationsShekhar B Yeshwante, Patrick Hanafin, Brittany K Miller, et al.
Plos Pathogens|February 22, 2023
Human ACE2 expression, a major tropism determinant for SARS-CoV-2, is regulated by upstream and intragenic elementsJohn N Snouwaert, Leigh A Jania, Trang Nguyen, et al.
Plos Pathogens|September 7, 2021
Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infectionQibin Geng, Wanbo Tai, Victoria K Baxter, et al.
Vaccines|January 26, 2024
Host Genetic Variation Impacts SARS-CoV-2 Vaccination Response in the Diversity Outbred Mouse PopulationMarta C Cruz Cisneros, Elizabeth J Anderson, Brea K Hampton, et al.
Cell Reports|March 31, 2023
Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccinationLily E Adams, Sarah R Leist, Kenneth H Dinnon, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2022
Fc mediated pan-sarbecovirus protection after alphavirus vector vaccinationLily E Adams, Sarah R Leist, Kenneth H Dinnon, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2017
ADP-ribosylhydrolase activity of Chikungunya virus macrodomain is critical for virus replication and virulenceRobert Lyle McPherson, Rachy Abraham, Easwaran Sreekumar, et al.
Plos One|December 11, 2013
Serum albumin and body weight as biomarkers for the antemortem identification of bone and gastrointestinal disease in the common marmosetVictoria K Baxter, Gillian C Shaw, Nathaniel P Sotuyo, et al.
Plos Pathogens|July 10, 2026
Characterization of an immunocompetent, young adult mouse model for studying chikungunya virus neuroinvasion and central nervous system infectionAlyssa M Lantz, Freedom M Green, Amanda J Cowan, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Pharmacokinetic considerations for optimizing inhaled spray-dried pyrazinoic acid formulationsShekhar B Yeshwante, Patrick Hanafin, Brittany K Miller, et al.
Molecular Pharmaceutics|August 17, 2023
Pharmacokinetic Considerations for Optimizing Inhaled Spray-Dried Pyrazinoic Acid FormulationsShekhar B Yeshwante, Patrick Hanafin, Brittany K Miller, et al.
Plos Pathogens|February 22, 2023
Human ACE2 expression, a major tropism determinant for SARS-CoV-2, is regulated by upstream and intragenic elementsJohn N Snouwaert, Leigh A Jania, Trang Nguyen, et al.
Plos Pathogens|September 7, 2021
Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infectionQibin Geng, Wanbo Tai, Victoria K Baxter, et al.
Vaccines|January 26, 2024
Host Genetic Variation Impacts SARS-CoV-2 Vaccination Response in the Diversity Outbred Mouse PopulationMarta C Cruz Cisneros, Elizabeth J Anderson, Brea K Hampton, et al.
Cell Reports|March 31, 2023
Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccinationLily E Adams, Sarah R Leist, Kenneth H Dinnon, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2022
Fc mediated pan-sarbecovirus protection after alphavirus vector vaccinationLily E Adams, Sarah R Leist, Kenneth H Dinnon, et al.
Pageof 5